The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
AN2 Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2022 to Q4 2023.
AN2 Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2023 was 875 %, a 58.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q4 2023
875
-1.25K
-58.8%
Dec 31, 2023
Q3 2023
991
-1.38K
-58.2%
Sep 30, 2023
Q2 2023
1.26K
Jun 30, 2023
Q1 2023
1.7K
Mar 31, 2023
Q4 2022
2.12K
Dec 31, 2022
Q3 2022
2.37K
Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.